Related Experiment Video
Updated: Jul 17, 2026
11:13
Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats
Published on: April 17, 2013
Aminoglycoside accumulation kinetics in rat renal parenchyma
Antimicrobial Agents and Chemotherapy
|January 1, 1983
Summary
Aminoglycoside accumulation in kidneys, particularly gentamicin, correlates with nephrotoxicity. Dosing frequency significantly impacts drug accumulation, influencing potential kidney damage.
Area of Science:
- Pharmacology
- Nephrology
- Toxicology
Background:
- Aminoglycosides are potent antibiotics frequently associated with kidney toxicity.
- Understanding the factors influencing aminoglycoside accumulation in renal tissue is crucial for predicting and mitigating nephrotoxicity.
Purpose of the Study:
- To investigate the relationship between renal parenchymal accumulation kinetics of aminoglycosides and their potential for nephrotoxicity.
- To compare the accumulation patterns of gentamicin and tobramycin in rat kidneys.
- To evaluate the impact of single versus multiple daily dosing regimens on aminoglycoside accumulation.
Main Methods:
- Renal parenchymal concentrations of gentamicin and tobramycin were measured in rats.
- Different dosing regimens, including single daily injections and multiple doses, were administered.
- Drug accumulation levels were quantified and compared between the two antibiotics and across different dosing strategies.
Main Results:
- Gentamicin demonstrated significantly higher accumulation in kidney tissue compared to tobramycin.
- Twice-daily administration of gentamicin resulted in more rapid accumulation and higher peak concentrations than the same total daily dose given once.
- The study established a clear dependency of aminoglycoside renal accumulation on both the specific drug and the dosing schedule.
Conclusions:
- Aminoglycoside accumulation in the renal parenchyma is a key factor influenced by drug properties and administration frequency.
- Observed differences in accumulation kinetics between gentamicin and tobramycin, and across dosing regimens, likely contribute to their varying degrees of nephrotoxicity.
- These findings suggest that monitoring renal accumulation could be a valuable strategy for predicting and managing aminoglycoside-induced kidney injury.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
Related Concept Videos
01:15Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
01:28Renal Drug Excretion: Tubular Secretion
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:20Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...